Navigation Links
Omni Bio Pharmaceutical Realigns Management
Date:2/24/2011

DENVER, Feb. 24, 2011 /PRNewswire/ -- (OTC Bulletin Board: OMBP):  Omni Bio Pharmaceutical, Inc. ("Omni Bio") today announced that effective March 1, 2011, Dr. James Crapo will become its Chief Executive Officer.  The board of directors of the Company anticipates appointing Dr. Crapo as a director in the near term.  Dr. Charles Dinarello, who has served as Omni Bio's acting Chief Executive Officer since its inception in March 2009, will become Omni's Chief Scientific Officer and Chief Medical Director.  Dr. Dinarello will oversee Omni Bio's plan to expand its activities in filing for new IND's ("Investigational New Drug Application") for human clinical trials in additional immunological and infectious disease classifications.  Dr. Crapo commented, "The science being developed by Omni Bio regarding new clinical indications for Alpha-1 antitrypsin ("AAT") is extremely exciting and I believe that it promises to be a major advance in the prevention and control of multiple human diseases.  It will be a privilege to help move this field of work as rapidly as possible into approved clinical applications."

Dr. Crapo has served on Omni Bio's Scientific Advisory Board since March 2009. He is currently a Professor at National Jewish Medical and Research Center and served as its Executive Vice President of Academic Affairs and Chairman of Medicine from June 1996 to 2004.  His prior business experience includes serving as CEO of Aeolus Pharmaceuticals, Inc. in 2004.  Aeolus is focused on developing a new class of metalloporphyrins for use as catalytic antioxidants.  He currently serves on the Board of Lifevantage Corporation, a maker of science-based solutions to oxidative stress.  He was the first scientist to extend Dr. Irwin Fridovich's and Dr. Joe McCord's original discovery of superoxide dismutase, a natural
'/>"/>

SOURCE Omni Bio Pharmaceutical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
2. Par Pharmaceutical Reports Second Quarter 2008 Results
3. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
4. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
5. ADVENTRX Pharmaceuticals to Report Second Quarter 2008 Results
6. Huifeng Bio-Pharmaceutical (HFGB) Announces USD $1.1 Million Supply Agreement with DNP International Co. Inc.
7. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121, an ErbB3 Antagonist
8. VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference
9. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
10. Access Pharmaceuticals to Present at the Noble Financial Equity Conference
11. Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... REDWOOD CITY, Calif. , March 4, 2015 ... ACRX ), a specialty pharmaceutical company focused on ... the treatment of acute and breakthrough pain, today ... yearly 2014 financial results after market close on ... an investment-community conference call at 4:30 p.m. Eastern ...
(Date:3/4/2015)... March 4, 2015 Vegalab announced the acquisition ... of last year. As part of the acquisition, Ecowin ... continuing his role as CEO for the company,s ... S.A., will work alongside Koo and oversee developments at ... http://photos.prnewswire.com/prnh/20150303/179218 Koo founded Ecowin in ...
(Date:3/4/2015)... PARIS , March 4, 2015 ... de Paris in December 2011, ... study of yttrium-90 resin microspheres versus sorafenib in advanced ... results expected late 2016.   SARAH, a ... liver cancer (hepatocellular carcinoma, or HCC) has completed patient ...
(Date:3/4/2015)... 4, 2015   ... Diagnostik und Therapie, Strahlendosismanagement und IT-Lösungen für die ... Royal Philips (NYSE: PHG, AEX: PHIA) gab ... (ECR) bekannt, der vom 4. bis 8. März in ... Ständen Nr. 102 and 110 wird ...
Breaking Biology Technology:AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 2AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 3Korean Government Program Supports Vegalab's Research and Development 2Korean Government Program Supports Vegalab's Research and Development 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 2Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 4Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 5Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 2Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 3Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 4Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 5Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 6
... 2011 At the White House today, President Barack ... U.S. recipients of the 2010 Kavli Prizes to recognize ... for which the Prizes are awarded -- astrophysics, nanoscience ... Joined by the President,s science advisor, John ...
... Kingdom, June 6, 2011 Oxford BioMedicaplc ... gene therapy company, today announces that it has signed ... biotechnology company specialising in the development of engineered antibody ... engineer an in vivo diagnostic imaging agent ...
... Biosciences, a leading innovator in protein diagnostics, announces ... allows researchers to cost effectively accelerate their research ... Avantra,s proven QPDx™ BioChip platform. The QPDx™ platform ... using catalog or custom reagents. Avantra,s ...
Cached Biology Technology:President Obama Meets U.S. Laureates of 2010 Kavli Prizes 2President Obama Meets U.S. Laureates of 2010 Kavli Prizes 3Oxford BioMedica Announces 5T4 Antibody Research Collaboration with ImaginAb 2Oxford BioMedica Announces 5T4 Antibody Research Collaboration with ImaginAb 3
(Date:3/3/2015)... LAKE FOREST, Calif. , March 3, ... ("Company"), the leading provider of advanced cryogenic ... serving markets including immunotherapies, stem cells, cell ... health, and reproductive medicine, today announced the ... Hutchinson Cancer Research Centers, ("Fred Hutch") ...
(Date:2/25/2015)... 2015  ABC Financial Services (ABC), the leading ... and Fitness Industry, today announced enhancements to their ... latest upgrade includes advances to the agreement section ... via Identity One fingerprint biometrics. The features will ... displays at the International Health, Racquet & Sportsclub ...
(Date:2/23/2015)... Feb. 23, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... patent 62114357 for DISTRIBUTED VOICE DIRECTED PAYMENT ... introduces a new groundbreaking payment method. Payment accounts may ... may only be accessed if both the speech (the ...
Breaking Biology News(10 mins):Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3
... is based on detecting short, repetitive DNA segments in ... such characteristic repeats. "With this method we are able ... genetic relationships. Furthermore, we can show how new pathogenic ... The results have now been published in the current ...
... represent the cellular backup of our brain. These cells ... or differentiate into neurons, astrocytes or oligodendrocytes. Astrocytes have ... form the myelin layer around axons in order to ... stem cell know" which way it is supposed to ...
... Netherlands: Transferring just one embryo at a time to ... diagnosis (PGD) and freezing at the blastocyst stage has ... that were as good as those for blastocysts that ... freezing. Their results mean that it will be possible ...
Cached Biology News:The tiny difference in the genes of bacteria 2Neural stem cell differentiation factor discovered 2Single thawed embryo transfer after PGD does not affect pregnancy rates 2Single thawed embryo transfer after PGD does not affect pregnancy rates 3
Goat polyclonal to T7 tag (Agarose) Immunogen: Goats were immunized with MASMTGGQQMG (T7) conjugated to KLH.After multiple immunizations in Freund's adjuvant, serum was collected....
Insect Cell Lysis Buffer 50 ml...
Mouse monoclonal [11C9] to Zeralenone ( Abpromise for all tested applications). Antigen: Chemical / Small Molecule conjugated to BSA: Zeralenone...
Fas-ligand rabbit polyclonal antibody...
Biology Products: